Cancer Research UK Science and Innovation shared on LinkedIn:
“Many congratulations to all the researchers receiving awards from our Research Careers Committee.
These awards support early to mid-career cancer researchers to develop, establish their independence and transition into leaders in their fields.
This round’s awardees are tackling many priority areas in cancer research, including deciphering how ‘immunologically cold’ glioblastomas evade conventional immunotherapies, determining how cellular senescence impacts anti-tumour t-cell responses in liver cancer and using gene editing to map vulnerabilities in uveal melanoma.
Clinician Scientist Fellowship
- Jenny Pui Ying Chan (Wellcome Sanger Institute)
- Chris Jones (University of Cambridge)
Career Development Fellowship
- Gabriele Picco (University of Cambridge)
- Riccardo Mezzadra (Cancer Research UK Scotland Institute)
Advanced Clinician Scientist Fellowship
- Thomas Wälchli (UCL, UCL Faculty of Medical Sciences, UCL Cancer Institute)
Cancer Research UK/The Pathological Society of Great Britain and Ireland Predoctoral Research Bursary
- Ernest Chi Hei Lee (King’s College London)
- Melanie Jensen (UCL Great Ormond Street Institute of Child Health)
Predoctoral Research Bursary
- Mzamo Mbelle (King’s College London)
Find out more about the awardees and their projects here: Research Careers Committee awards.”
To which Chris Jones, CRUK Clinician Scientist Fellow at University of Cambridge, added:
“I am thrilled to be starting this Clinician Scientist Fellowship and very grateful to Cancer Research UK (CRUK) for their funding.
It is exciting to have an opportunity to continue to build our research focussed on developing and improving responses from targeted radionuclide therapies.
This is a real inflection point in the development of this potentially transformative treatment approach and I am very much looking forward to contributing to its growth alongside collaborators at Memorial Sloan Kettering Cancer Center (Jason Lewis), University of Birmingham (Paul Moss) and King’s College London (Samantha Terry), and with Rebecca Fitzgerald (Early Cancer Institute, University of Cambridge) and Sir Stephen (Steve) Jackson (Cancer Research UK Cambridge Institute) here in Cambridge.
None of this would be possible without the incredible support I have received from so many mentors and colleagues across the oncology, oesophagogastric and endocrine fields, for which I am immensely grateful.”
Other articles about Cancer Research UK Science and Innovation on OncoDaily.
